Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 17, 2019

Primary Completion Date

October 31, 2022

Study Completion Date

October 31, 2022

Conditions
Secondary Osteoporosis
Interventions
DRUG

Colaren in HIV positive

1 Arm (HIV+): will receive Zoledronic acid 4mg and colaren ® (vitamin D, magnesium, phosphate, calcium).

DRUG

standard treatment in HIV positive

2 Arm (HIV+): will receive Zoledronic acid 4mg and standard treatment (vitamin D and calcium carbonate)

DRUG

Colaren in HIV negative

3 Arm (HIV-): will receive Zoledronic acid 4mg and colaren ® (vitamin D, magnesium, phosphate, calcium).

DRUG

standard treatment in HIV negative

4 Arm (HIV-): will receive Zoledronic acid 4mg and standard treatment (vitamin D and calcium carbonate)

Trial Locations (1)

44280

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara

All Listed Sponsors
collaborator

Hospital Civil de Guadalajara

OTHER

lead

University of Guadalajara

OTHER

NCT03930992 - Efficacy of Zoledronic Acid + Colaren vs Zoledronic Acid + Conventional Treatment for Osteoporosis in HIV+ and HIV- Men | Biotech Hunter | Biotech Hunter